Synthetic membrane-targeted antibiotics

Current Medicinal Chemistry

Volumn 17, Issue 21, 2010, Pages 2292-2300

  Vooturi, S K ^a   Firestine, S M ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

Antibiotic resistance; Antibiotics; Antimicrobial peptides; Bacterial membranes; Foldamers

Indexed keywords

ALPHA PEPTIDE DERIVATIVE; AMINO ACID; BENZOPHENONE DERIVATIVE; BETA PEPTIDE DERIVATIVE; BOMBININ; CERAGENIN DERIVATIVE; CSA 13; CYCLOPEPTIDE; DAPTOMYCIN; GENTAMICIN; GLYCOPEPTIDE; LINEZOLID; LIPOPEPTIDE; MAGAININ DERIVATIVE; OLIGOMER; PEPTIDOMIMETIC AGENT; PEPTOID; POLYMER; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; ANTIMICROBIAL CATIONIC PEPTIDE; MOLECULAR LIBRARY; PEPTIDE;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BACILLUS SUBTILIS; BACTERIAL INFECTION; BACTERIAL MEMBRANE; DIASTEREOISOMER; DRUG COST; DRUG POTENCY; DRUG STRUCTURE; DRUG TARGETING; ESCHERICHIA COLI; HUMAN; MEMBRANE PERMEABILITY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; VANCOMYCIN RESISTANT ENTEROCOCCUS; VANCOMYCIN RESISTANT STAPHYLOCOCCUS AUREUS; CELL MEMBRANE; CHEMISTRY; DRUG EFFECTS; MOLECULAR LIBRARY; PHARMACOLOGY;

ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; CELL MEMBRANE; DRUG RESISTANCE, BACTERIAL; PEPTIDES; POLYMERS; SMALL MOLECULE LIBRARIES;

EID: 77955626468     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986710791331059     Document Type: Article

References (61)

1. Gould, I. M. Antibiotic resistance: the perfect storm. Int. J. Antimicrob. Agents, 2009, 34, S2-5.
2. Klevens, R.M.; Morrison, M.A.; Nadle, J.; Petit, S.; Gershman, K.; Ray, S.; Harrison, L.H.; Lynfield, R.; Dumyati, G.; Townes, J.M.; Craig, A.S.; Zell, E.R.; Fosheim, G.E.; McDougal, L.K.; Carey, R.B.; Fridkin, S.K. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA, 2007, 298, 1763-71.
3. Lode, H. Management of serious nosocomial bacterial infections: do current therapeutic options meet the need? Clin. Microbiol. Infect., 2005, 11, 778-87.
4. Tsiodras, S.; Gold, H.S.; Sakoulas, G.; Eliopoulos, G.M.; Wennersten, C.; Venkataraman, L.; Moellering, R.C.; Ferraro, M.J., Linezolid resistance in a clinical isolate of Staphylococcus aureus. Lancet, 2001, 358, 207-8.
5. Mangili, A.; Bica, I.; Snydman, D.R.; Hamer, D.H. Daptomycinresistant, methicillin-resistant Staphylococcus aureus bacteremia. Clin. Infect. Dis., 2005, 40, 1058-60.
6. Zasloff, M., Antimicrobial peptides of multicellular organisms. Nature, 2002, 415, 389-95.
7. Scott, R.W.; DeGrado, W.F.; Tew, G.N. De novo designed synthetic mimics of antimicrobial peptides. Curr. Opin. Biotechnol., 2008, 19, 620-7.
8. Brogden, K.A. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat. Rev. Microbiol., 2005, 3, 238-50.
9. Hancock, R.E. Peptide antibiotics. Lancet, 1997, 349, 418-22.
10. Bechinger, B. Structure and functions of channel-forming peptides: magainins, cecropins, melittin and alamethicin. J. Membr. Biol., 1997, 156, 197-211.
11. Hancock, R.E.; Sahl, H.G. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat. Biotechnol., 2006, 24, 1551-7.
12. Van Bambeke, F.; Mingeot-Leclercq, M.P.; Struelens, M.J.; Tulkens, P.M. The bacterial envelope as a target for novel anti- MRSA antibiotics. Trends Pharmacol. Sci., 2008, 29, 124-34.
13. Mangoni, M.L.; Papo, N.; Saugar, J.M.; Barra, D.; Shai, Y.; Simmaco, M.; Rivas, L. Effect of natural L- to D-amino acid conversion on the organization, membrane binding, and biological function of the antimicrobial peptides bombinins H. Biochemistry, 2006, 45, 4266-76.
14. Saravanan, R.; Bhunia, A.; Bhattacharjya, S. Micelle-bound structures and dynamics of the hinge deleted analog of melittin and its diastereomer: Implications in cell selective lysis by d-amino acid containing antimicrobial peptides. Biochim. Biophys. Acta, 2010, 1798, 128-139.
15. Braunstein, A.; Papo, N.; Shai, Y. In vitro activity and potency of an intravenously injected antimicrobial peptide and its DL amino acid analog in mice infected with bacteria. Antimicrob. Agents Chemother., 2004, 48, 3127-9.
16. Fernandez-Lopez, S.; Kim, H. S.; Choi, E. C.; Delgado, M.; Granja, J.R.; Khasanov, A.; Kraehenbuehl, K.; Long, G.; Weinberger, D.A.; Wilcoxen, K.M.; Ghadiri, M.R. Antibacterial agents based on the cyclic D,L-alpha-peptide architecture. Nature, 2001, 412, 452-5.
17. Dartois, V.; Sanchez-Quesada, J.; Cabezas, E.; Chi, E.; Dubbelde, C.; Dunn, C.; Granja, J.; Gritzen, C.; Weinberger, D.; Ghadiri, M.R.; Parr, T.R., Jr. Systemic antibacterial activity of novel synthetic cyclic peptides. Antimicrob. Agents Chemother., 2005, 49, 3302-10.
18. Motiei, L.; Rahimipour, S.; Thayer, D. A.; Wong, C.H.; Ghadiri, M.R. Antibacterial cyclic D,L-alpha-glycopeptides. Chem. Commun. (Camb.), 2009, 25, 3693-5.
19. Patch, J.A.; Barron, A.E. Mimicry of bioactive peptides via nonnatural, sequence-specific peptidomimetic oligomers. Curr. Opin. Chem. Biol., 2002, 6, 872-7.
20. Tew, G.N.; Scott, R.W.; Klein, M.L.; Degrado, W.F. De Novo Design of Antimicrobial Polymers, Foldamers, and Small Molecules: From Discovery to Practical Applications. Acc. Chem. Res., 2010, 43, 30-9.
21. Porter, E.A.; Weisblum, B.; Gellman, S.H. Use of parallel synthesis to probe structure-activity relationships among 12-helical betapeptides: evidence of a limit on antimicrobial activity. J. Am. Chem. Soc., 2005, 127, 11516-29.
22. Watson, J.L.; Gillies, E.R. Amphipathic beta-strand mimics as potential membrane disruptive antibiotics. J. Org. Chem., 2009, 74, 5953-60.
23. Steer, D.L.; Lew, R.A.; Perlmutter, P.; Smith, A.I.; Aguilar, M.I. Beta-amino acids: versatile peptidomimetics. Curr. Med. Chem., 2002, 9, 811-22.
24. Schmitt, M.A.; Weisblum, B.; Gellman, S.H. Unexpected relationships between structure and function in alpha,beta-peptides: antimicrobial foldamers with heterogeneous backbones. J. Am. Chem. Soc., 2004, 126, 6848-9.
25. Schmitt, M.A.; Weisblum, B.; Gellman, S.H. Interplay among folding, sequence, and lipophilicity in the antibacterial and hemolytic activities of alpha/beta-peptides. J. Am. Chem. Soc., 2007, 129, 417-28.
26. Robinson, J.A. Beta-hairpin peptidomimetics: design, structures and biological activities. Acc. Chem. Res., 2008, 41, 1278-88.
27. Rodziewicz-Motowidlo, S.; Mickiewicz, B.; Greber, K.; Sikorska, E.; Szultka, L.; Kamysz, E.; Kamysz, W. Antimicrobial and conformational studies of the active and inactive analogues of the protegrin-1 peptide. FEBS J., 2010, 277, 1010-22.
28. Shankaramma, S.C.; Athanassiou, Z.; Zerbe, O.; Moehle, K.; Mouton, C.; Bernardini, F.; Vrijbloed, J.W.; Obrecht, D.; Robinson, J.A. Macrocyclic hairpin mimetics of the cationic antimicrobial peptide protegrin I: a new family of broad-spectrum antibiotics. Chembiochem, 2002, 3, 1126-33.
29. Robinson, J.A.; Shankaramma, S.C.; Jetter, P.; Kienzl, U.; Schwendener, R.A.; Vrijbloed, J.W.; Obrecht, D. Properties and structure-activity studies of cyclic beta-hairpin peptidomimetics based on the cationic antimicrobial peptide protegrin I. Bioorg. Med. Chem., 2005, 13, 2055-64.
30. Srinivas, N.; Moehle, K.; Abou-Hadeed, K.; Obrecht, D.; Robinson, J.A. Biaryl amino acid templates in place of D-Pro-L-Pro in cyclic beta-hairpin cationic antimicrobial peptidomimetics. Org. Biomol. Chem., 2007, 5, 3100-5.
31. Frecer, V. QSAR analysis of antimicrobial and haemolytic effects of cyclic cationic antimicrobial peptides derived from protegrin-1. Bioorg. Med. Chem., 2005, 14, 6065-6074.
32. Patch, J.A.; Barron, A.E. Helical peptoid mimics of magainin-2 amide. J. Am. Chem. Soc., 2003, 125, 12092-3.
33. Chongsiriwatana, N.P.; Patch, J.A.; Czyzewski, A.M.; Dohm, M.T.; Ivankin, A.; Gidalevitz, D.; Zuckermann, R.N.; Barron, A.E. Peptoids that mimic the structure, function, and mechanism of helical antimicrobial peptides. Proc. Natl. Acad. Sci. U. S. A., 2008, 105, 2794-9.
34. Ryge, T.S.; Hansen, P.R. Potent antibacterial lysine-peptoid hybrids identified from a positional scanning combinatorial library. Bioorg. Med. Chem., 2006, 14, 4444-51.
35. Ryge, T.S.; Frimodt-Moller, N.; Hansen, P.R. Antimicrobial activities of twenty lysine-peptoid hybrids against clinically relevant bacteria and fungi. Chemotherapy, 2008, 54, 152-6.
36. Olsen, C.A.; Bonke, G.; Vedel, L.; Adsersen, A.; Witt, M.; Franzyk, H.; Jaroszewski, J.W. Alpha-peptide/beta-peptoid chimeras. Org. Lett., 2007, 9, 1549-52.
37. De Lucca, A.J.; Walsh, T.J. Antifungal peptides: novel therapeutic compounds against emerging pathogens. Antimicrob. Agents Chemother., 1999, 43, 1-11.
38. Resh, M.D. Fatty acylation of proteins: new insights into membrane targeting of myristoylated and palmitoylated proteins. Biochim. Biophys. Acta, 1999, 145, 1-16.
39. Avrahami, D.; Shai, Y. A new group of antifungal and antibacterial lipopeptides derived from non-membrane active peptides conjugated to palmitic acid. J. Biol. Chem., 2004, 279, 12277-85.
40. Makovitzki, A.; Avrahami, D.; Shai, Y. Ultrashort antibacterial and antifungal lipopeptides. Proc. Natl. Acad. Sci. U. S. A., 2006, 103, 15997-6002.
41. Thennarasu, S.; Lee, D.K.; Tan, A.; Prasad Kari, U.; Ramamoorthy, A. Antimicrobial activity and membrane selective interactions of a synthetic lipopeptide MSI-843. Biochim. Biophys. Acta, 2005, 1711, 49-58.
42. Radzishevsky, I.S.; Rotem, S.; Bourdetsky, D.; Navon-Venezia, S.; Carmeli, Y.; Mor, A. Improved antimicrobial peptides based on acyl-lysine oligomers. Nat. Biotechnol., 2007, 25, 657-9.
43. Radzishevsky, I.S.; Kovachi, T.; Porat, Y.; Ziserman, L.; Zaknoon, F.; Danino, D.; Mor, A. Structure-activity relationships of antibacterial acyl-lysine oligomers. Chem. Biol., 2008, 15, 354-62.
44. Sarig, H.; Livne, L.; Held-Kuznetsov, V.; Zaknoon, F.; Ivankin, A.; Gidalevitz, D.; Mor, A. A miniature mimic of host defense peptides with systemic antibacterial efficacy. FASEB J., 2010, doi:10.1096/ fj.09-149427.
45. Gottler, L.M.; Lee, H.Y.; Shelburne, C.E.; Ramamoorthy, A.; Marsh, E.N. Using fluorous amino acids to modulate the biological activity of an antimicrobial peptide. Chembiochem, 2008, 9, 370-3.
46. Tew, G.N.; Liu, D.; Chen, B.; Doerksen, R.J.; Kaplan, J.; Carroll, P.J.; Klein, M.L.; DeGrado, W.F. De novo design of biomimetic antimicrobial polymers. Proc. Natl. Acad. Sci. U.S.A., 2002, 99, 5110-4.
47. Tew, G.N.; Clements, D.; Tang, H.; Arnt, L.; Scott, R.W. Antimicrobial activity of an abiotic host defense peptide mimic. Biochim. Biophys. Acta Biomemb., 2006, 1758, 1387-92.
48. Tang, H.; Doerksen, R.J.; Tew, G.N. Synthesis of urea oligomers and their antibacterial activity. Chem. Commun. (Camb.), 2005, 12, 1537-9.
49. Violette, A.; Fournel, S.; Lamour, K.; Chaloin, O.; Frisch, B.; Briand, J.P.; Monteil, H.; Guichard, G. Mimicking helical antibacterial peptides with nonpeptidic folding oligomers. Chem. Biol., 2006, 13, 531-8.
50. Mowery, B.P.; Lee, S.E.; Kissounko, D.A.; Epand, R.F.; Epand, R.M.; Weisblum, B.; Stahl, S.S.; Gellman, S.H. Mimicry of antimicrobial host-defense peptides by random copolymers. J. Am. Chem. Soc., 2007, 129, 15474-6.
51. Lienkamp, K.; Madkour, A.E.; Musante, A.; Nelson, C.F.; Nusslein, K.; Tew, G.N. Antimicrobial polymers prepared by ROMP with unprecedented selectivity: a molecular construction kit approach. J. Am. Chem. Soc., 2008, 130, 9836-43.
52. Lienkamp, K.; Tew, G.N. Synthetic mimics of antimicrobial peptides-- a versatile ring-opening metathesis polymerization based platform for the synthesis of selective antibacterial and cellpenetrating polymers. Chemistry, 2009, 15 (44), 11784-800.
53. Palermo, E.F.; Kuroda, K. Chemical structure of cationic groups in amphiphilic polymethacrylates modulates the antimicrobial and hemolytic activities. Biomacromolecules, 2009, 10, 1416-28.
54. Kuroda, K.; Caputo, G.A.; DeGrado, W.F. The role of hydrophobicity in the antimicrobial and hemolytic activities of polymethacrylate derivatives. Chemistry, 2009, 15, 1123-33.
55. Lai, X.Z.; Feng, Y.; Pollard, J.; Chin, J.N.; Rybak, M.J.; Bucki, R.; Epand, R.F.; Epand, R.M.; Savage, P.B. Ceragenins: cholic acidbased mimics of antimicrobial peptides. Acc. Chem. Res., 2008, 41, 1233-40.
56. Chin, J.N.; Rybak, M.J.; Cheung, C.M.; Savage, P.B. Antimicrobial activities of ceragenins against clinical isolates of resistant Staphylococcus aureus. Antimicrob. Agents Chemother., 2007, 51, 1268-73.
57. Isogai, E.; Isogai, H.; Takahashi, K.; Okumura, K.; Savage, P.B. Ceragenin CSA-13 exhibits antimicrobial activity against cariogenic and periodontopathic bacteria. Oral Microbiol. Immunol., 2009, 24, 170-2.
58. Haug, B.E.; Stensen, W.; Kalaaji, M.; Rekdal, O.; Svendsen, J.S. Synthetic antimicrobial peptidomimetics with therapeutic potential. J. Med. Chem., 2008, 51, 4306-14.
59. Strom, M.B.; Haug, B.E.; Skar, M.L.; Stensen, W.; Stiberg, T.; Svendsen, J.S. The pharmacophore of short cationic antibacterial peptides. J. Med. Chem., 2003, 46, 1567-70.
60. Hansen, T.; Alst, T.; Havelkova, M.; Strom, M.B. Antimicrobial activity of small beta-peptidomimetics based on the pharmacophore model of short cationic antimicrobial peptides. J. Med. Chem., 2010, 53, 595-606.
61. Vooturi, S.K.; Cheung, C.M.; Rybak, M.J.; Firestine, S.M. Design, synthesis, and structure-activity relationships of benzophenonebased tetraamides as novel antibacterial agents. J. Med. Chem., 2009, 52, 5020-31.